|
|
|
|
Vol. 302, Issue 2, 627-635, August 2002
Department of Physiology and Pharmacology, University of New South
Wales, Sydney, New South Wales, Australia
The characteristics of
[125I]Bolton-Hunter[Sar9,Met(O2)11]substance
P ([125I]BH-SarSP) binding were investigated in membranes
of human ascending, transverse, distal, and sigmoid colon circular
muscle. Binding of [125I]BH-SarSP was of high affinity
(KD = 68 nM) and low capacity (Bmax = 0.31 fmol/mg of wet weight
tissue), and showed no regional differences.
[125I]BH-SarSP binding was inhibited by SP
[Pro9]SP
(2S,3S)-3-(2-methoxybenzylamino)-2-phenylpiperidine
(CP99994)
neurokinin (NK) A
neuropeptide
> [Lys5,MeLeu9,Nle10]-NKA(4-10)
(S)-N-methyl-N[4-acetylamino-4-phenylpiperidino)-2-(3,4-dichlorophenyl) butyl]benzamide (SR48968)
senktide, suggesting binding to
NK-1 sites. Most agonists seemed to bind to two sites. In
autoradiographic studies, dense binding for
[125I]BH-SarSP was associated with submucosal and
longitudinal muscle blood vessels, and the submucosal margin of
circular muscle (corresponding to interstitial cells of Cajal), with
moderate binding over most of the circular muscle. In normal colon
circular muscle strips, [Pro9]SP was almost ineffective,
and SP caused contractions with pD2 values of 5.3 to 5.7. No regional differences were observed in potency or efficacy. Responses
to SP were inhibited by the NK-2 receptor antagonist SR48968, but not
by NK-1 antagonist CP99994, indicating the involvement of NK-2 rather
than NK-1 receptors. Atropine significantly inhibited contractions
induced by SP, indicating a minor cholinergic component. Contractile
responses to SP were considerably reduced in preparations from patients
with diverticular disease, and marginally reduced in ulcerative colitis
compared with control. This study clearly demonstrates an NK-1 binding site on human colon circular muscle, but its role in this tissue remains unclear and may not involve contractile mechanisms. The attenuated contractility in specimens with diverticular disease may
reflect disease-related alterations of the tachykinin receptor system.
This article has been cited by other articles:
![]() |
L. Liu, F. Shang, M. J. Morgan, D. W. King, D. Z. Lubowski, and E. Burcher Cyclooxygenase-Dependent Alterations in Substance P-Mediated Contractility and Tachykinin NK1 Receptor Expression in the Colonic Circular Muscle of Patients with Slow Transit Constipation J. Pharmacol. Exp. Ther., April 1, 2009; 329(1): 282 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Burcher, F. Shang, F. J. Warner, Q. Du, D. Z. Lubowski, D. W. King, and L. Liu Tachykinin NK2 Receptor and Functional Mechanisms in Human Colon: Changes with Indomethacin and in Diverticular Disease and Ulcerative Colitis J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 170 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, D. Redelman, S. Ro, S. M. Ward, T. Ordog, and K. M. Sanders Selective labeling and isolation of functional classes of interstitial cells of Cajal of human and murine small intestine Am J Physiol Cell Physiol, January 1, 2007; 292(1): C497 - C507. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Kovac, T. Chrones, H. G. Preiksaitis, and S. M. Sims Tachykinin Receptor Expression and Function in Human Esophageal Smooth Muscle J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 513 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Guagnini, M Valenti, S Mukenge, I Matias, A Bianchetti, S Di Palo, G Ferla, V Di Marzo, and T Croci Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance P Gut, July 1, 2006; 55(7): 946 - 953. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cao, K. M. Harnett, and V. E. Pricolo NK2 Receptor-Mediated Spontaneous Phasic Contractions in Normal and Ulcerative Colitis Human Sigmoid Colon J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1349 - 1355. [Abstract] [Full Text] [PDF] |
||||